The National Institute of Statistical Sciences (NISS) is pleased to announce a series of Webinars on: Unplanned Clinical Trial Disruptions.
During the first two sessions, leading government agency representatives will discuss how COVID-19 has resulted in unprecedented disruptions to ongoing clinical trials. Clinical trials have been forced to break protocol by, for example, halting enrollment, altering the timing and type of data collection, conducting an unplanned interim analysis. Many data collection appointments were canceled, postponed, or substituted by "virtual" procedures. For more information on this NISS hosted Ingram Olkin Forum series and to register, click here. Or copy to your browser: https://www.niss.org/events/ingram-olkin-forum-series-unplanned-clinical-trial-disruptions
After each of these webinars, you will be given the opportunity to indicate your interest in participating in the subsequent small group workshop sessions to be scheduled after JSM.
------------------------------
James Rosenberger
Professor Emeritus of Statistics
Pennsylvania State University and NISS
------------------------------